RAMM Pharma (XCNQ:RAMM) Total Receivables: C$0.45 Mil (As of Jan. 2026)


What is RAMM Pharma Total Receivables?

RAMM Pharma XCNQ:RAMM Total Receivables is C$0.45 Mil as of Jan. 2026. The stock has 4 warning signs investors should review.

RAMM Pharma's Total Receivables for the quarter that ended in Jan. 2026 was C$0.45 Mil.

RAMM Pharma Total Receivables Historical Data

* Premium members only.

The historical data trend for RAMM Pharma's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RAMM Pharma Total Receivables Chart

RAMM Pharma Annual Data
Trend Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
Total Receivables
Get a 7-Day Free Trial 3.95 2.74 1.88 1.64 0.88

RAMM Pharma Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.73 1.60 1.56 0.88 0.45

RAMM Pharma Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of C$0.45 Mil mean?
RAMM Pharma (XCNQ:RAMM) has a Total Receivables of C$0.45 Mil as of Jan. 2026. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on RAMM Pharma and its competitors.
Is RAMM Pharma's Total Receivables too high?
RAMM Pharma's current Total Receivables is C$0.45 Mil.
How does RAMM Pharma's Total Receivables compare to ZTS and UTHR?
RAMM Pharma's Total Receivables of C$0.45 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Drug Manufacturers company?
A good Total Receivables depends on the Drug Manufacturers industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on RAMM Pharma and its competitors. RAMM Pharma's current Total Receivables is C$0.45 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RAMM Pharma stock overvalued right now?
Based on GuruFocus' analysis, RAMM Pharma (XCNQ:RAMM) is currently considered Fairly Valued. The stock's GF Value™ is C$0.01, compared to a current price of C$0.01 — trading right at its estimated fair value. The current Total Receivables is C$0.45 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For RAMM Pharma (XCNQ:RAMM), the current Total Receivables is C$0.45 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

RAMM Pharma Business Description

Address 82 Richmond Street E, Toronto, ON, CAN, M5C 1P1
RAMM Pharma Corp is engaged in the pharmaceutical and medical product business, including cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products. The group generates revenue from the sale of medical devices and consumables, the sale of pharmaceutical products, and sale of cosmetics. Geographically, it derives a majority of its revenue from Uruguay.